As compared with chemotherapy-naive patients (2.533 ± 0.141 ng/mL), HPN concentration was higher (p = 0.036) in CRC patients treated with chemotherapy (3.201 ± 0.225 ng/mL). The gene discussed is HPN; the disease is colorectal carcinoma.